UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000010401 |
|---|---|
| Receipt number | R000011434 |
| Scientific Title | Phase II study of induction therapy with subcutaneous bortezomib, oral melphalan and predonisone for newly diagnosed multiple myeloma patients ineligible for stem cell transplantation |
| Date of disclosure of the study information | 2013/04/03 |
| Last modified on | 2019/04/09 09:37:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/04/02 17:42:18 | ||
| 2 | Update | 2013/11/02 16:08:19 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 3 | Update | 2014/11/09 15:37:43 | Key exclusion criteria Key exclusion criteria |
|
| 4 | Update | 2014/11/10 00:23:52 | Email Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Organization1 Address1 Tel1 Email1 |
|
| 5 | Update | 2016/04/05 20:04:29 | Name of primary person or sponsor Institute Institute Organization |
|
| 6 | Update | 2017/04/04 18:24:58 | Recruitment status |
|
| 7 | Update | 2019/04/09 09:37:01 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
